37.92
price up icon1.46%   0.365
 
loading
Schlusskurs vom Vortag:
$37.56
Offen:
$37.68
24-Stunden-Volumen:
124.48K
Relative Volume:
0.18
Marktkapitalisierung:
$1.40B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-39.51
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
-1.06%
1M Leistung:
-20.90%
6M Leistung:
+53.86%
1J Leistung:
-15.42%
1-Tages-Spanne:
Value
$37.31
$38.53
1-Wochen-Bereich:
Value
$36.20
$39.30
52-Wochen-Spanne:
Value
$20.85
$54.19

Harrow Inc Stock (HROW) Company Profile

Name
Firmenname
Harrow Inc
Name
Telefon
615.733.4731
Name
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
Mitarbeiter
382
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
HROW's Discussions on Twitter

Vergleichen Sie HROW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
37.85 1.39B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.84 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.41 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.2433 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.09 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
447.64 19.53B 3.08B 1.24B 1.07B 25.61

Harrow Inc Stock (HROW) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-11 Eingeleitet Cantor Fitzgerald Overweight
2025-06-12 Eingeleitet BTIG Research Buy
2025-06-10 Eingeleitet William Blair Outperform
2025-02-06 Eingeleitet H.C. Wainwright Buy
2024-12-04 Bestätigt B. Riley Securities Buy
2024-04-11 Eingeleitet Craig Hallum Buy
2022-09-08 Fortgesetzt B. Riley Securities Buy
2021-10-14 Fortgesetzt B. Riley Securities Buy
2021-09-24 Eingeleitet Aegis Capital Buy
2021-07-02 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Harrow Inc Aktie (HROW) Neueste Nachrichten

pulisher
06:20 AM

Best data tools to analyze Harrow Inc. stockWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com

06:20 AM
pulisher
06:10 AM

Can Harrow Inc. stock sustain market leadershipWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com

06:10 AM
pulisher
05:56 AM

How Harrow Inc. stock reacts to global recession fearsProfit Target & Weekly Market Pulse Alerts - newser.com

05:56 AM
pulisher
04:52 AM

Why Harrow Inc. stock is in analyst buy zone2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

04:52 AM
pulisher
01:29 AM

What insider trading reveals about Harrow Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com

01:29 AM
pulisher
Oct 30, 2025

What risks investors should watch in Harrow Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Harrow Inc. stock pay special dividends2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Corrado Advisors LLC Purchases Shares of 7,366 Harrow, Inc. $HROW - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Custom watchlist performance reports with Harrow Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What is the fair value of Harrow Inc. stock now2025 Price Targets & Free Verified High Yield Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Analyzing Harrow Inc. with risk reward ratio chartsPortfolio Profit Report & Trade Opportunity Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Key resistance and support levels for Harrow Inc.July 2025 Setups & Verified Swing Trading Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Should you hold or exit Harrow Inc. now2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

D.A. Davidson & CO. Sells 13,255 Shares of Harrow, Inc. $HROW - MarketBeat

Oct 28, 2025
pulisher
Oct 27, 2025

Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Kornitzer Capital Management Inc. KS Acquires New Position in Harrow, Inc. $HROW - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Bleakley Financial Group LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Will Harrow Inc. stock keep outperforming rivalsDollar Strength & Real-Time Market Trend Scan - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Harrow (NASDAQ:HROW) - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Sundram Fasteners Limited (SUNDRMFAST) to Launch New Product LineChart Pattern Recognition & Double Or Triple Investment - earlytimes.in

Oct 26, 2025

Finanzdaten der Harrow Inc-Aktie (HROW)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Harrow Inc-Aktie (HROW) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Opaleye Management Inc.
10% Owner
Jun 10 '25
Sale
30.80
15,000
462,033
90,000
Opaleye Management Inc.
10% Owner
Jun 09 '25
Sale
30.37
15,204
461,794
105,000
Opaleye Management Inc.
10% Owner
Jun 03 '25
Sale
30.04
3,000
90,116
122,000
Opaleye Management Inc.
10% Owner
Jun 04 '25
Sale
30.02
1,796
53,907
120,204
Opaleye Management Inc.
10% Owner
May 12 '25
Sale
25.90
10,000
258,959
130,000
Opaleye Management Inc.
10% Owner
May 13 '25
Sale
26.59
5,000
132,945
125,000
BOLL ANDREW R.
Chief Financial Officer
Apr 03 '25
Option Exercise
0.00
346,500
0
914,589
SAHAREK JOHN P.
CEO & President, ImprimisRx
Apr 03 '25
Option Exercise
0.00
277,200
0
576,863
BAUM MARK L
Chief Executive Officer
Apr 03 '25
Option Exercise
0.00
762,300
0
2,899,825
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
30.01
5,000
150,055
140,000
$46.91
price up icon 6.10%
drug_manufacturers_specialty_generic RDY
$13.31
price down icon 1.04%
$22.70
price up icon 0.55%
$10.39
price up icon 0.25%
$140.50
price up icon 1.73%
$448.78
price down icon 1.16%
Kapitalisierung:     |  Volumen (24h):